One year: In the us, the studies of Herceptin (trastuzumab) looked at a full year of treatment for patients with curable breast cancer. Herceptin (trastuzumab) is given every three weeks for 17 doses. But why a year? It was chosen at random. In finland, a similar study gave only 9 weeks of herceptin (trastuzumab)... And patients did just as well! so, a year or less is the best answer. You don't need more!
Answered 6/25/2014
5.2k views
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question